Deep Intelligent Pharma (DIP) has raised $15 million in a Series B funding from Sequoia Capital China, with the proceeds to be used for accelerating the development of the company’s artificial intelligence (AI) powered drug discovery platform.
The China and US-based company was founded in 2017 by CEO Xing Li, who previously spent 11 years working on new drug development for the likes of Pfizer, Sanofi, and Johnson & Johnson. It runs a project...
Private equity compensation rose across the board in Asia Pacific last year – a trend that is seen to reflect rising competition for talent as the number of firms and volume of capital in the region continues to grow.
Indian restaurant discovery and food delivery platform Zomato has raised $210 million from existing investor Ant Financial, the financial services affiliate of China’s Alibaba Group.
The Carlyle Group and Chinese healthcare services provider Meinian Onehealth have together invested in Adicon Holding, a local independent clinical laboratory (ICL) provider. Carlyle is now the company's single largest shareholder.
IDG Ventures India has changed its name to Chiratae Ventures to emphasize the firm’s identity as a backer of high-growth Indian start-ups with potential for global expansion.